I think it is funny how some are freaking out here. The actions of the company are great for the shareholders imo. Why keep burning cash on the RMAT process when USRM is already making cash with treatments in place now. opening more clinics and growing the revenue pools are what is important right now. Myocell will continue to take off slowly, but the adipocell treatments for stuff like joint rehab for physical therapy is the GOLDMINE here!! I am 100% for them focusing on the CASH BALANCE and therefore raising the stock price.
Market Data 
Markets 
AI
